Organon Operating Income 2019-2024 | OGN

Organon operating income from 2019 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Organon Operating Income 2019-2024 | OGN

Organon operating income from 2019 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$98B
Cencora (COR)$48.9B
DiDi Global (DIDIY)$23.6B
ICON (ICLR)$17.7B
Natera (NTRA)$16.6B
Viatris (VTRS)$15.5B
Avantor (AVTR)$15.4B
Revvity (RVTY)$14.9B
BioMerieux (BMXMF)$13.1B
CochLear (CHEOY)$12.6B
Solventum (SOLV)$12.5B
Medpace Holdings (MEDP)$11.3B
Charles River Laboratories (CRL)$11B
Doximity (DOCS)$10.8B
HealthEquity (HQY)$8.6B
Sonic Healthcare (SKHHY)$8.5B
Bausch + Lomb (BLCO)$7B
Life Times (LTH)$5.2B
Sotera Health (SHC)$4.6B
Surgery Partners (SGRY)$3.9B
BrightSpring Health Services (BTSG)$3.4B
PACS (PACS)$3.3B
Alignment Healthcare (ALHC)$2.6B
Concentras Parent (CON)$2.5B
Ardent Health Partners (ARDT)$2.3B
Premier (PINC)$2.3B
GeneDx Holdings (WGS)$2.1B
Ryman Healthcare (RYHTY)$2B
GoodRx Holdings (GDRX)$1.9B
Teladoc Health (TDOC)$1.6B